Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...

Biogen said on Friday it has gained global rights to privately held Vanqua Bio's experimental drug for up to $1.06 billion to ...

Biogen and partner UCB recently announced upcoming presentations at the American College of Rheumatology 2025 conference highlighting positive Phase 3 data for dapirolizumab pegol in treating systemic ...

The Valhalla Foundation awarded Octave Bioscience funding to further develop a biomarker blood test for assessing disease ...

Yaron invented a “brainwave helmet” that helps patients recover after a stroke. Experts said it was a crazy idea and would ...

Anthony Durkacz, Executive Co-Chairman of Quantum BioPharma added, “We are very excited about the potential of Lucid-MS as a first-in-class treatment for MS targeting demyelination. With these final ...

The company will use the funds to drive commercial growth, broaden its employer and payer programs, and accelerate AI ...

Zenas BioPharma said on Wednesday it has secured global rights to develop and commercialize an experimental drug from China-based InnoCare Pharma for multiple sclerosis and other autoimmune conditions ...

Australia's medical cannabis industry is "excessively" prescribing weed with little oversight and needs urgent regulation, ...

Some observers said the industry was too often issuing prescriptions without “proper clinical oversight”. Read more at ...

The Series A funding round was led by General Catalyst, a venture capital firm that has supported the growth of companies ...